How Much Help Do Health Care Systems Need to Survive Coronavirus?
How much additional funding would it actually take to enable the health care system to continue functioning at close to normal capacity?
Health Care Finance
-
Read more: How Much Help Do Health Care Systems Need to Survive Coronavirus? -
Read more: Hospital Administration and the COVID-19 Pandemic (Part II) Hospital Administration and the COVID-19 Pandemic (Part II)
A discussion of administrative decisions hospitals are making during the COVID-19 pandemic, including cutting benefits for employees and furloughing staff.
-
Read more: Hospital Administration and the COVID-19 Pandemic (Part I) Hospital Administration and the COVID-19 Pandemic (Part I)
An overview of for-profit and not-for-profit hospital administration, which lays the groundwork for understanding the crises that hospitals currently face.
-
Read more: Debt, Dignity, and Health Care: Guaranteeing Health Rights and Universal Health Coverage Debt, Dignity, and Health Care: Guaranteeing Health Rights and Universal Health Coverage
RecordingDescription Each year in low- and middle-income countries thousands of people are detained in hospitals for non-payment of medical bills, despite the fact that such detention is a violation of national and international law. Hospital detention for nonpayment of bills disproportionately affects the most vulnerable people, including post-partum women. In the US, medical debt manifests…
-
Read more: Private Funding of Drug Discovery: Ethical Issues, Practical Alternatives: A Health Policy and Bioethics Consortium Private Funding of Drug Discovery: Ethical Issues, Practical Alternatives: A Health Policy and Bioethics Consortium
Description The traditional model for drug development begins with publicly-funded science based in academic or government laboratories before private investors and for-profit pharmaceutical manufacturers become involved with their substantial expertise and resources. This for-profit drug development model has been criticized for leaving certain public health issues unaddressed, particularly diseases prevalent in low-resource settings. What is…
-
Read more: Lessons from Germany on Controlling Prescription Costs Lessons from Germany on Controlling Prescription Costs
RecordingDescription To control the costs of prescription drugs, Germany combines immediate access to innovative drugs with price controls. The system assesses scientific evidence on the value of new drugs to determine adequate price ranges. While price controls are supervised by the government, the system is administered by public sickness funds, an independent scientific institute, and…
-
Read more: Why Our Health Care Is Incomplete: Review of “Exposed” (Part II) Why Our Health Care Is Incomplete: Review of “Exposed” (Part II)
By: Daniel Aaron Just last month, Professor Christopher T. Robertson, at the University of Arizona College of Law, released his new book about health care, entitled Exposed: Why Our Health Insurance Is Incomplete and What Can Be Done About It. Part II of this book review offers an analytical discussion of “cost exposure,” the main…
-
Read more: Why Our Health Care Is Incomplete: Review of “Exposed” (Part I) Why Our Health Care Is Incomplete: Review of “Exposed” (Part I)
By Daniel Aaron Just last month, Professor Christopher T. Robertson, at the University of Arizona College of Law, released his new book about health care, entitled Exposed: Why Our Health Insurance Is Incomplete and What Can Be Done About It. This book review will offer an analytical discussion of “cost exposure,” the main subject of…
-
Read more: Recent Litigation Developments Regarding Drug Pricing and Access Recent Litigation Developments Regarding Drug Pricing and Access
This post originally appeared on SLS Blogs and is reposted with permission of the author. You can read the piece in its entirety here. By Rebecca Wolitz With multi-million dollar treatments entering the market, prescription drug costs accounting for between 15-17% of healthcare expenditures, and nearly 1 in 4 Americans unable to afford a prescription medication in the past 12…
-
Read more: One of the Biggest Public Health Initiatives in History: PEPFAR and HIV One of the Biggest Public Health Initiatives in History: PEPFAR and HIV
By Daniel Aaron In October, the Petrie-Flom Center hosted a conference of world-leading experts in HIV/AIDS to discuss one of the biggest public health successes in history: PEPFAR, the President’s Emergency Plan for AIDS Relief. PEPFAR was launched in 2003 in response to a burgeoning global epidemic of HIV. The program offered $2 billion annually,…
